| Product Code: ETC8890538 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Oncology NGS Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Oncology NGS Market - Industry Life Cycle |
3.4 Portugal Oncology NGS Market - Porter's Five Forces |
3.5 Portugal Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Portugal Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Portugal Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Portugal Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Portugal Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Portugal Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Portugal |
4.2.2 Technological advancements in Next-Generation Sequencing (NGS) for oncology |
4.2.3 Growing demand for personalized medicine and targeted therapies in oncology |
4.3 Market Restraints |
4.3.1 High costs associated with NGS technologies and tests |
4.3.2 Limited reimbursement policies for NGS-based oncology tests in Portugal |
5 Portugal Oncology NGS Market Trends |
6 Portugal Oncology NGS Market, By Types |
6.1 Portugal Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Portugal Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Portugal Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Portugal Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Portugal Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Portugal Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Portugal Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Portugal Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Portugal Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Portugal Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Portugal Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Portugal Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Portugal Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Portugal Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Portugal Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Portugal Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Portugal Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Portugal Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Portugal Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Portugal Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Portugal Oncology NGS Market Import-Export Trade Statistics |
7.1 Portugal Oncology NGS Market Export to Major Countries |
7.2 Portugal Oncology NGS Market Imports from Major Countries |
8 Portugal Oncology NGS Market Key Performance Indicators |
8.1 Adoption rate of NGS technology in oncology diagnostics and treatment |
8.2 Number of research collaborations between academic institutions, hospitals, and biotech companies in the field of oncology NGS |
8.3 Percentage increase in the number of oncologists trained in utilizing NGS technologies for patient care |
9 Portugal Oncology NGS Market - Opportunity Assessment |
9.1 Portugal Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Portugal Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Portugal Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Portugal Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Portugal Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Portugal Oncology NGS Market - Competitive Landscape |
10.1 Portugal Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Portugal Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here